Hydropothecary (TSWX:HEXO) has announced it has reached a significant milestone in its expansions plans.
As quoted in the press release:
Health Canada has given final licensing for an advanced manufacturing facility that includes areas for dewaxing, distillation, milling and extraction that will provide HEXO the capability to transform, manufacture and package cannabis into a wide range of products. The expansion also includes secondary trimming zones, large storage areas and cleaning rooms.
These expanded capabilities will allow HEXO to continue to improve its existing products while simultaneously equipping the Company for the next round of products to become available under regulations.
The manufacturing area facilitates even larger scale production of the Company’s award-winning, smoke-free products such as Decarb, an activated cannabis powder, Elixir, a sublingual cannabis oil, and the newly-launched Fleur de Lune, an intimate medical cannabis oil. The expansion also gives HEXO optimal positioning as the Company continue to prepare for the future adult-use beverage and edible cannabis market.
“We are extremely proud to offer multiple, award-winning, smoke-free cannabis products,” said Adam Miron, HEXO’s CBO and co-founder.
“This manufacturing expansion allows us to continue offering the smoke-free products that we are already known for, while constantly developing new, innovative ways for our medical and future adult-use clients to consume cannabis,” added Mr. Miron.